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ensorimotor Gating Depends on Polymorphisms of
he Serotonin-2A Receptor and Catechol-O-
ethyltransferase, but Not on Neuregulin-1 Arg38Gln
enotype: A Replication Study
oris B. Quednow, Anne Schmechtig, Ulrich Ettinger, Nadine Petrovsky, David A. Collier,
ranz X. Vollenweider, Michael Wagner, and Veena Kumari
ackground: Prepulse inhibition (PPI) of the acoustic startle response (ASR) is an operational measure of sensorimotor gating and a
romising endophenotype of schizophrenia. We have recently shown that the linked serotonin-2A receptor (5-HT2AR) A-1438 G and T102C
olymorphismsmodulate PPI in schizophrenia patients. Moreover, it was shown that genetic variation in the catechol-O-methyltransferase
COMT) and the neuregulin-1 (NRG-1) proteins influences PPI in schizophrenia patients and healthy volunteers. Therefore, we aimed to
eplicate these results and investigated the impact of the related polymorphisms on PPI in healthy human volunteers.
ethods: We analyzed the 5-HT2AR A-1438 G/T102C (rs6311/rs6313), the COMT Val158Met (rs4680), and the NRG-1 Arg38Gln (rs3924999)
olymorphisms, assessing startle reactivity, habituation, and PPI of ASR in 107 healthy Caucasian volunteers.
esults: Subjects homozygous for the 5-HT2AR T102C-T/A-1438G-A allele showed increased PPI levels. In particular,male subjectswith the
OMT Met158Met-genotype also showed elevated PPI. The NRG-1 Arg38Gln genotype did not have a significant impact on PPI. Startle
eactivity was not affected by any of the investigated polymorphisms.
onclusions: Weconfirmed in an independent sampleof healthy volunteers that PPI is influencedbygenetic variation in the5-HT2ARgene.
he influence of the COMTVal158Met genotype on PPI appears to be sex-specific. These results underscore the significance of the serotonin
nd dopamine systems in the modulation of sensorimotor gating.ey Words: 5-HT2A receptor, acoustic startle response, polymor-
hism, prepulse inhibition, schizophrenia, sensorimotor gating,
erotonin-2A receptor
repulse inhibition (PPI) of the acoustic startle response
(ASR) is widely used as an operational measure of senso-
rimotor gating (1). PPI refers to the reduction of ASR
agnitude when a distinctive nonstartling stimulus is presented
0–500 msec before a startling stimulus (2). It was proposed that
he mechanism underlying PPI regulates sensory input by filter-
ng out irrelevant or distracting stimuli to prevent sensory
nformation overflow (1).
PPI was suggested as a promising endophenotype of
chizophrenia for several reasons (3): 1) schizophrenia pa-
ients consistently show PPI deficits (4), 2) unaffected first-
egree relatives of schizophrenia patients also exhibit de-
reased PPI levels (5,6), 3) the PPI deficit seems to be a trait
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oi:10.1016/j.biopsych.2009.05.007marker of schizophrenia because it is already present in the
prodromal phase of schizophrenia (7), 4) Inbred rodent
studies and human twin studies suggested that PPI is heritable
(8–10), and 5) PPI is measurable in a wide range of species in
which PPI deficits could be artificially induced by environ-
mental or pharmacologic manipulations. This offers the pos-
sibility to study the neurobiological basis of PPI in transla-
tional investigations (1).
Several single nucleotide polymorphisms (SNPs) have been
reported to affect PPI strongly, thereby illuminating both the
molecular mechanisms and genetic influences on sensorimo-
tor gating. Initially, Hong et al. (11) found that the neuregu-
lin-1 (NRG-1) Arg38Gln SNP modulates PPI in healthy volun-
teers and schizophrenia patients. Roussos et al. (12) followed
with their finding that the catechol-O-methyltransferase
(COMT) Val158Met SNP affects PPI in healthy male volunteers,
a discovery which we recently replicated in a mixed-sex
sample of schizophrenia patients (13). Additionally, we
showed that the serotonin-2A receptor (5-HT2AR) A-1438 G
and T102C SNPs (which are in complete linkage disequilib-
rium) are associated with PPI in schizophrenia patients (14).
Most recently, it has been demonstrated that PPI also depends
on the dopamine-D3 receptor Ser9Gly SNP (15). All of these
SNPs have at some stage been suggested as susceptibility
polymorphisms for schizophrenia (e.g., 16,17), but current meta-
analyses do not support their role in etiology of the disease
itself—with the exception of the 5-HT2AR A-1438 G polymor-
phism, which may have a small effect on the risk for schizophre-
nia (SchizophreniaGene: http://www.schizophreniaforum.org/res/
sczgene) (18).
Replication is essential for establishing the credibility of
genotype–phenotype associations (19). Therefore, we inves-
tigated the impact of four SNPs, which were previously linked
BIOL PSYCHIATRY 2009;66:614–620
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B.B. Quednow et al. BIOL PSYCHIATRY 2009;66:614–620 615o sensorimotor gating and schizophrenia, on PPI in a new and
ndependent sample of healthy human volunteers: The linked
-HT2AR T102C/A-1438 G, the COMT Val158Met, and the
RG-1 Arg38Gln polymorphisms.
ethods andMaterials
articipants
One hundred seven healthy Caucasian volunteers (49.5%
omen; 24.3% smokers; mean age 26.2  5.8 [SD] years, range:
8–43) were recruited through local advertisements in South
ondon, United Kingdom. Participants were screened for the
xclusion criteria of DSM-IV Axis I disorders using the Structured
linical Interview for DSM-IV Disorders (SCID-I). Additional
xclusion criteria were a history of head injuries, any known
eurological abnormalities or systemic illness with known neu-
ological complication, a first-degree relative with psychosis or
bsessive-compulsive disorder, and a history of substance abuse
r dependence. Ethical approval of the local ethics committee
as obtained, and participants provided written informed con-
ent.
enotyping
DNA was obtained from venal blood or buccal swabs using
stablished procedures (20). 5-HT2AR A-1438 G (rs6311) and
102C (rs6313), COMT Val158Met (rs4680), and NRG-1 Arg38Gln
rs3924999) SNP genotyping assays were run as submicroliter
olymerase chain reaction–based assays on Array Tape (http://
ww.douglasscientific.com) at PreventionGenetics (Marshfield,
isconsin). They used an allele-specific polymerase chain reac-
ion assay as described by Myakishev et al. (21) (rs6313,
s3924999) or InvaderPlus reactions from Third Wave Technol-
gies (Madison, Wisconsin) (rs4680, rs6311). To improve geno-
yping reliability, many samples of similar DNA quality and
oncentration were genotyped at the same time. Genotyping was
uccessful in 93.5% of subjects for 5-HT2AR A-1438 G and T102C,
able 1. Demographic Data and Psychophysiological Parameters of Health
eceptor Genotype
-HT2A A-1,438 G Genotype (rs6311) AA
-HT2A T102C Genotype (rs6313) TT
19 (19.6%)
ge 26.8 (1.7)
ears of Education 16.8 (.9)
en, % 36.8
mokers, % 36.8
irst Block, Amplitude of Pulse-Alone Trialsa
(Arbitrary Units) 742 (95.3)
ean Amplitude of Pulse-Alone Trialsa (Arbitrary
Units) 561 (84.3)
ean Percent Prepulse Inhibitiona (Mean Across
Three SOA Conditions) 41.3 (3.3)
ercent Early Habituation of Pulse-Alone Trialsa
(Between First and Second Block) 19.2 (6.3)
ercent Total Habituation of Pulse-Alone Trialsa
(Between First and Last Block) 34.2 (7.6)
abituation of Pulse-Alone Trials Across Four Blocksa
(Linear Gradient Coefficient b) 90.8 (19.4) 
Means and SEM in parentheses, adjusted for sex and smoking; sex and s
ere in complete linkage disequilibrium.
5-HT2A, serotonin-2A receptor; SOA, stimulus-onset asynchronies.
aAnalysis of covariance, means adjusted by covariates sex and smoking
bSignificant p values.in 88.8% for COMT Val158Met, and in 95.3% for NRG-1 Arg38Gln
SNP.
Startle ResponseMeasurement
Equipment, set up, PPI testing, and data acquisition and
scoring procedures have previously been described in detail
(22). Each examination began with a 4-min acclimation period of
70-dB background noise that was continued throughout the
session. Participants received 49 white noise sound pulses at an
intensity of 115 dB (duration of 40 msec) separated by variable
intertrial intervals between 9 and 23 sec (mean  15 sec). In 36
of the trials, the pulse was preceded by a 20-msec, 85-dB
white-noise prepulse with stimulus-onset asynchronies (SOA) of
30, 60, and 120 msec (12 trials each). The initial trial was a
pulse-alone (PA) trial, which was separated for further analysis.
All following trials were presented in a pseudo-randomized
order. The entire test session lasted approximately 16 min. To
ensure that PPI was not influenced by smoking withdrawal,
smoking ad libitum was permitted before testing (23). Trial
exclusion and scoring criteria were identical to those used in
previous studies (24). Subjects with response rejections  50%
were excluded from data analysis (n  4).
Statistical Analysis
Startle reactivity was assessed by the mean amplitude of the
first block of PA trials and the mean amplitude of all PA trials. For
the assessment of startle habituation, PA trials were divided each
in four blocks. The calculation of the mean percent PPI and the
habituation measures (percent habituation and linear gradient
coefficient b) have been described in detail elsewhere (24).
All demographic data were analyzed by analysis of variance
(ANOVA) with exception of frequency data. Frequency data
were analyzed using 2 tests. Given that sex (25) and smoking
status (23) could affect PPI, these variables were introduced as
covariates in all analyses of covariance (ANCOVA) of the psy-
chophysiologic parameters independent of the statistical signifi-
man Volunteers Grouped According to Their 5-HT2A A-1438G and T102C
G GG
C CC Total F/2 df/dferr p 
2
3.3%) 36 (37.1%) 97 (100%)
(.9) 26.1 (.9) 26.1 (.6) .20 2/96 .82 .00
(.4) 17.8 (.6) 17.1 (.3) 1.35 2/96 .26 .03
.1 44.4 48.5 2.53 2 .28 —
.4 27.8 26.8 1.61 2 .45 —
4.1) 701 (68.5) 714 (41.0) .06 2/92 .94 .00
6.7) 590 (60.6) 580 (36.4) .04 2/92 .96 .00
(2.2) 31.2 (2.4) 31.9 (1.6) 5.28 2/92 .007b .10
(4.2) 16.9 (4.5) 20.2 (2.7) .61 2/92 .55 .01
(5.1) 26.0 (5.5) 28.9 (3.3) .38 2/92 .98 .01
(13.0) 60.5 (14.0) 68.4 (8.4) .86 2/92 .43 .02
ng in frequency data. 5-HT2A A-1438G and T102C receptor polymorphismsy Hu
A
T
42 (4
25.8
16.7
57
21
712 (6
578 (5
28.3
23.6
28.9
65.0
moki
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wance of the covariates. On the basis of significant main effects or
nteractions, Tukey honest significant difference (HSD) post hoc
omparisons were performed. Given that we proposed direc-
ional hypotheses regarding the genotype effects on sensorimo-
or gating, statistical comparisons of the PPI data were carried out
t a significance level set at p .05 (two-tailed). Considering that
e investigated four SNPs, all other confirmatory statistical
omparisons were carried out at a Bonferroni-corrected signifi-
ance level of p  .0125 (2-tailed). Within the Pearson Product-
oment correlation analyses, the significance level was set at p
01 (two-tailed) to avoid accumulation of alpha error. Effect size
alculations between two groups refer to Cohen’s d. When post
oc tests of PPI data are reported, Cohen’s d calculations based
n pooled SOA conditions.
esults
-HT2A T102C and A-1438 G Receptor Polymorphisms
As expected, the 5-HT2AR T102C and A-1438 G polymor-
hisms were in complete linkage disequilibrium (r2  1.0).
enotype frequencies were distributed in accordance with
ardy-Weinberg Equilibrium [HWE; 2(1)  1.1; p  .29]. The
enotype groups did not differ regarding demographic vari-
bles, startle reactivity, and habituation measures (see Table
). Moreover, startle latency and prepulse latency facilitation
as not affected by 5-HT2AR genotype (data not shown).
A 3  3 (SOA condition  genotype) repeated-measures
NCOVA with sex and smoking as covariates revealed signif-
cant main effects for the factors SOA condition [F (2,91)  7.7;
 .001; 2  .14], sex [F (1,92)  22.2; p  .001; 2  .19],
nd genotype [F (2,92)  5.0; p  .01; 2  .10; see Figure 1A].
ukey HSD post hoc tests revealed that homozygous carriers
f the T102C-T/A-1438 G-A allele did show significantly
igher PPI levels compared to homozygous T102C-C/A-1438
-G (p  .05; d  .63) and the heterozygous T102C-TC/A-
438 G-AG variants (p  .01; d  .81). Homozygous T102C-
/A-1438 G-G carriers and heterozygous T102C-TC/A-1438
-AG carriers did not differ in PPI. The main effect of SOA
eflects the well-known nature of PPI to increase with rising
OA from 30 msec through 60–120 msec (26). The effect of
ex points to the known fact that women have generally lower
PI levels than men [pooled SOA conditions: F (1,102)  18.3;
 .001; 2  .15] (25).
OMT Val158Met Polymorphism
The COMT Val158Met genotype frequencies were distributed
n accordance to the HWE [2(1)  1.9; p  .17]. The three
enotype groups did not differ in demographic characteristics,
ooled PPI scores, startle reactivity, and habituation measures
Table 2). Startle latency measures were also not influenced by
OMT genotype (data not shown).
The Met homozygotes displayed the highest PPI levels but a
 3 (SOA condition  genotype) repeated-measures ANCOVA
ith sex and smoking as covariates revealed only significant
ain effects for the factors SOA condition [F (2,87) 5.5; p .01;
2  .11] and sex [F (1,88)  13.7; p  .001; 2  .13; see Figure
B]. Given that Roussos et al. (12) showed their significant effects
f COMT genotype on PPI in male subjects only, we excluded
emales from the ANCOVA analysis in a further step. Although
nly 45 males remained, this resulted in a significant main effect
f genotype [F (2,41)  3.2; p  .05; 2  .13; see Figure 2].
ukey HSD post hoc tests revealed that Met homozygotes
isplayed significantly higher PPI levels compared with het-
ww.sobp.org/journalerozygotes (p  .05; d  .83). Both homozygous groups did not
significantly diverge with respect to PPI although the difference
did show a moderate effect size (d  .55). The ValVal group and
the ValMet group did not differ. The male COMT genotype
groups still did not differ in startle reactivity and habituation
measures. Moreover, if male Met homozygotes were compared
Figure 1. The effects of genotype onpercent prepulse inhibition (PPI) of the
acoustic startle response at prepulse (onset)-to-pulse (onset) intervals of 30,
60, and 120 msec in healthy human volunteers (means and SEM, adjusted
for sex and smoking): (A) the completely linked serotonin-2A receptor
(5-HT2A) A-1438G and T102C receptor polymorphisms (Tukey honest signif-
icant difference post hoc test vs. TT/AA allele group: *p  .05, **p  .01),
(B) the catechol O-methyltransferase (COMT) Val158Met polymorphism,
and (C) the neuregulin-1 (NRG-1) Arg38Gln polymorphism.with a merged group of male carriers of the Val Allel (ValMet 	
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easures ANCOVA with smoking as a covariate, the Met ho-
ozygotes still showed significantly higher PPI levels that Val
llele carriers [F (1,42)  6.3, p  .05, 2  .13].
RG-1 Arg38Gln Polymorphism
The NRG-1 Arg38Gln genotype frequencies were distrib-
ted in accordance with HWE [2(1)  .04; p  .84]. The three
enotype groups did not differ regarding demographic char-
cteristics, pooled PPI scores, startle reactivity, and startle
atency measures (see Table 3), but there was a trend for a
ifferent distribution of sex between the genotype groups.
oreover, there was a strong trend for a genotype effect
egarding early habituation (see Table 3). The total habitua-
ion and the slope of habituation revealed a similar but also
able 2. Demographic Data and Psychophysiological Parameters of Health
COMT) Val158Met Genotype
OMT Val158Met Genotype (rs4680) MetMet
22 (23.7%)
ge 25.9 (1.3)
ears of Education 16.3 (.7)
en, % 54.5
moker, % 27.3
irst Block, Amplitude of Pulse-Alone Trialsa (Arbitrary
Units) 775 (88.1)
ean Amplitude of Pulse-Alone Trialsa (Arbitrary
Units) 644 (76.6)
ean Percent Prepulse Inhibitiona (Mean Across
Three SOA Conditions) 35.8 (3.2)
ercent Early Habituation of Pulse-Alone Trialsa
(Between First and Second Block) 14.7 (5.8)
ercent Total Habituation of Pulse-Alone Trialsa
(Between First and Last Block) 28.7 (7.0)
abituation of Pulse-Alone Trials Across Four Blocksa
(Linear Gradient Coefficient b) 74.2 (17.8)
SOA, stimulus-onset asynchronies.
aAnalysis of covariance, means adjusted by covariates sex and smoking
igure 2. The effects of catechol-O-methyltransferase (COMT) Val158Met
enotype on percent prepulse inhibition (PPI) of the acoustic startle re-
ponse at prepulse (onset)-to-pulse (onset) intervals of 30, 60, and 120msec
n 45 healthy human male volunteers (means and SEM, adjusted for smok-
ng; Tukey honest significant difference post hoc test versus the MetMet-
roup. (*)p .08, *p .05).nonsignificant pattern of effect as observed for early habitua-
tion.
Although the A homozygotes showed somewhat higher PPI
levels, a 3  3 (SOA condition  genotype) repeated-measures
ANCOVA with sex and smoking as covariates revealed significant
main effects only for the factors SOA condition [F(2,93)  9.0;
p  .001; 2  .16], and sex [F (1,94)  18.1; p  .001; 2  .16;
see Figure 1C].
Correlation Analysis and Genotype Interactions
Age and years of education did not correlate with any of the
psychophysiologic parameters. A 3  3  3 (SOA condition 
SNP  genotype) repeated-measures ANCOVA with the three
SNPs under investigation and sex as covariate did not show any
significant interactions between SNPs. Interaction analyses with
two SNPs each did also not reveal any interactions. However,
these analyses should be interpreted with caution because of the
limited sample size.
Discussion
This work aimed to replicate initial findings on the depen-
dency of PPI on polymorphisms of the 5-HT2A receptor, the
COMT enzyme, and the NRG-1 signal protein in an indepen-
dent sample of healthy human volunteers. First, we confirmed
that the 5-HT2AR T102C/A-1438 G polymorphism exerts the
same impact on sensorimotor gating in healthy humans as was
previously shown in schizophrenia patients (14). Carriers of
the C102/G-1438 alleles exhibited a significantly lower PPI
than subjects homozygous for the T102/A-1438 alleles. Inter-
estingly, the PPI variance explained by these 5-HT2AR SNPs
was comparable between studies (schizophrenia patients:
11%; healthy control subjects: 10%), although we used differ-
ent PPI paradigms and recruited the subjects in different
European countries. Second, we were able to replicate the
finding that male COMT Val158Met Met homozygotes display
elevated PPI levels (12), but we were unable to detect this
effect in our total mixed-sex sample. Roussos et al. (12)
reported their COMT effects on PPI from a sample of male
man Volunteers Grouped According to Catechol-O-methyltransferase
lMet ValVal Total F/2 df/dferr p 
2
(57.0%) 18 (19.4%) 93 (100%)
4 (.9) 25.7 (.9) 26.2 (.6) .13 2/92 .88 .00
1 (.4) 17.5 (.8) 17.0 (.3) .79 2/92 .46 .02
5.3 50.0 48.4 .56 2 .76 —
8.3 16.7 25.8 .98 2 .61 —
(56.8) 749 (68.5) 718 (42.1) .42 2/88 .66 .01
(49.4) 559 (60.6) 580 (36.7) .45 2/88 .64 .01
2 (2.1) 34.3 (3.5) 32.3 (1.7) 1.28 2/88 .28 .03
5 (3.8) 26.0 (4.5) 20.6 (2.8) .89 2/88 .41 .02
0 (4.5) 35.8 (7.7) 28.6 (3.3) .60 2/88 .55 .01
1 (11.5) 97.9 (19.7) 69.1 (8.6) 1.65 2/88 .20 .04y Hu
Va
53
26.
17.
4
2
685
561
30.
21.
26.
57.students, and we initially confirmed this effect for schizophre-
www.sobp.org/journal
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wia patients in a sample consisting of nearly 70% males (13).
he fact that one study did not find an impact of that
olymorphism on PPI in female subjects (27) further supports
he notion that the COMT Val158Met genotype might affect
PI only in male subjects. Furthermore, the COMT Met158
llele has also been reported to have a greater impact on
ognitive functions and PPI-related personality traits in males
han females (28,29). The explained PPI variance by COMT
enotype for the males in our study was 13%, which is situated
etween the effect in Roussos male sample (25%) and our
ixed-sex schizophrenia sample (9%). Third, we could not
eplicate the finding of Hong et al. (11), who reported a
oderate impact of the NRG-1 Arg38Gln polymorphism on
PI previously (7.9% variance explanation by NRG-1 geno-
ype). In contrast to the lowered PPI levels in the homozygous
allele carriers in Hong’s sample, we rather found slightly
levated PPI levels in this group. Thus, it is unlikely that our
tudy was simply underpowered to generate the same effect.
he mixed sample of Hong et al. (11) was indeed larger than
urs but was heterogeneous, consisting of Caucasian and
frican Americans, schizophrenia patients, and healthy con-
rol subjects, whereas our sample includes exclusively Cauca-
ian healthy control subjects. Finally, Hong et al. assessed PPI
nly at an SOA of 120 msec, and they used a slightly weaker
repulse intensity (80 vs. 85 dB). However, a selective analysis
f our 120 msec SOA condition still revealed a different PPI
attern (AA  GG  AG), which could not be explained by
he slightly different prepulse intensity. Thus, the discrepant
esults may be most likely caused by different sample com-
ositions.
Importantly, our finding on the 5-HT2AR polymorphisms
atch nearly all criteria for a replication of a genotype–pheno-
ype association proposed by the National Cancer Institute–
ational Human Genome Research Institute (NCI-NHGRI) Work-
ng Group on Replication in Association Studies (19): 1) we used
larger size than reported in the initial report, 2) we generated
n independent data set, 3) we assessed the same phenotype, 4)
able 3. Demographic Data and Psychophysiological Parameters of Health
rg38Gln Genotype
RG-1 Arg38Gln Genotype (rs3924999) AA
13 (13.1%)
ge 26.9 (1.9)
ears of Education 17.2 (.6)
en, % 30.8
mokers, % 7.7
irst Block, Amplitude of Pulse-Alone Trialsa
(Arbitrary Units) 848 (114.7) 6
ean Amplitude of Pulse-Alone Trialsa (Arbitrary
Units) 650 (101.7) 5
ean Percent Prepulse Inhibitiona (Mean Across
Three SOA Conditions) 35.6 (4.3)
ercent Early Habituation of Pulse-Alone Trialsa
(Between First and Second Block) 25.6 (7.5)
ercent Total Habituation of Pulse-Alone Trialsa
(Between First and Last Block) 46.3 (9.0)
abituation of Pulse-Alone Trials Across 4 Blocksa
(Linear Gradient Coefficient b) 113.5 (23.1) 
Means and standard error of means in parentheses, adjusted for sex and
SOA, stimulus-onset asynchronies.
aAnalysis of covariance, means adjusted by covariates sex and smokinge found similar effect sizes in the same SNPs, 5) we used the
ww.sobp.org/journalsame statistical tests, 6) we had a rationale for reassessing these
SNPs (susceptibility genes of schizophrenia), and 7) we provide
at least the same level of detail for study design, analysis, and
sample characteristics as reported in the initial study. Moreover,
all analyzed genotype frequencies were distributed in accor-
dance to the HWE so that genetic inhomogeneity of the investi-
gated population is unlikely.
Our meta-analyses of the SchizophreniaGene online database
revealed that among the four genetic variants investigated in our
study, only the 5-HT2AR A-1438 G polymorphism is likely associ-
ated with the risk for schizophrenia (5-HT2AR A-1438 G: odds
ratio in Caucasians [OR]  1.17; COMT Val158Met: OR  1.01;
NRG-1 Arg38Gln: OR  .97; http://www.schizophreniaforum.org)
(18). Lower PPI in carriers of the 5-HT2AR A-1438 G-G variant
would therefore be consistent with the significant association of
this allele with schizophrenia and the well-known PPI deficits in
schizophrenia. The 5-HT2AR T102C and the A-1438 G polymor-
phism are silent mutations, but both may alter promoter activity
and expression of 5-HT2ARs (30,31). Thus, the C allele of the
T102C variation or the G allele of the A-1438-G variation (or
both) may cause lower 5-HT2AR densities in several brain areas
that are involved in the processing of sensorimotor gating
(14,32). Additionally, PPI deficits have also been reported in
obsessive-compulsive disorder (33,34) and autism (35,36), in
which both the 5-HT2AR A-1438 G polymorphism have been
implicated (37,38). Then again, although local administration of
dopamine agonists, antagonists, or depleters in the prefrontal
cortex (PFC) disrupts PPI (39–43), there is some indirect evi-
dence that the COMT antagonist tolcapone, which slightly in-
creases dopamine in the PFC, improves PPI in COMT Val158-
homozygotes (44). Thus, the increased PPI in male Met158
homozygotes could possibly be explained by a slight increase of
dopamine in the PFC. However, more research is required to
clarify the neurobiological basis of the COMT-genotype effect on
PPI.
In conclusion, our findings support the view that sensorimo-
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revious human and animal findings showing that PPI is affected
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pistatic effects of different gene mutations on PPI, which may
rovide also windows into the polygenetic causation of schizo-
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